CorMedix
CRMD
#6147
Rank
A$1.36 B
Marketcap
A$17.27
Share price
-2.13%
Change (1 day)
31.19%
Change (1 year)

Earnings for CorMedix (CRMD)

Earnings in 2025 (TTM): A$0.16 Billion

According to CorMedix's latest financial reports the company's current earnings are A$0.21 Billion. In 2024 the company made an earning of -A$29.04 Million, an increase over its 2023 earnings that were of -A$69.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CorMedix from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.16 B-668.84%
2024 -A$29.04 Million-58.3%
2023 -A$69.64 Million53%
2022 -A$45.52 Million2.81%
2021 -A$44.28 Million8.32%
2020 -A$40.87 Million26.53%
2019 -A$32.3 Million-19.89%
2018 -A$40.32 Million-18.72%
2017 -A$49.61 Million34.56%
2016 -A$36.87 Million34.88%
2015 -A$27.34 Million-11.08%
2014 -A$30.74 Million124.69%
2013 -A$13.68 Million144.91%
2012 -A$5.59 Million-48.41%
2011 -A$10.83 Million-33.29%
2010 -A$16.23 Million78.42%
2009 -A$9.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
A$2.83 B 1,662.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.24 B 54.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$23.27 M-85.53%๐Ÿ‡บ๐Ÿ‡ธ USA